Cell Calcium, ISSN 0143-4160, 07/2001, Volume 30, Issue 1, pp. 19 - 27
During increases in cardiac work there are net increases in cytosolic [Ca2+] and ATP hydrolysis by myofiliments and ion transport ATPases. However, it is still...
RAT HEARTS | OXIDATIVE-PHOSPHORYLATION | RUTHENIUM RED | P-31 NMR | OXYGEN-CONSUMPTION | RESPIRATORY CONTROL | MYOCYTES | INTACT HEART | INTRACELLULAR CALCIUM | MUSCLE-CELLS | CELL BIOLOGY | Membrane Potentials - drug effects | Mitochondria, Heart - enzymology | Mitochondria, Heart - drug effects | Membrane Potentials - physiology | NAD - drug effects | Oxygen Consumption - physiology | Oxidative Phosphorylation - drug effects | Animals | Calcium - physiology | Mitochondria, Heart - physiology | Oxygen Consumption - drug effects | Swine | Adenosine Triphosphate - metabolism | Cell Respiration - drug effects | Cell Respiration - physiology | Adenosine Diphosphate - metabolism | Adenosine Triphosphatases - physiology | NAD - metabolism
RAT HEARTS | OXIDATIVE-PHOSPHORYLATION | RUTHENIUM RED | P-31 NMR | OXYGEN-CONSUMPTION | RESPIRATORY CONTROL | MYOCYTES | INTACT HEART | INTRACELLULAR CALCIUM | MUSCLE-CELLS | CELL BIOLOGY | Membrane Potentials - drug effects | Mitochondria, Heart - enzymology | Mitochondria, Heart - drug effects | Membrane Potentials - physiology | NAD - drug effects | Oxygen Consumption - physiology | Oxidative Phosphorylation - drug effects | Animals | Calcium - physiology | Mitochondria, Heart - physiology | Oxygen Consumption - drug effects | Swine | Adenosine Triphosphate - metabolism | Cell Respiration - drug effects | Cell Respiration - physiology | Adenosine Diphosphate - metabolism | Adenosine Triphosphatases - physiology | NAD - metabolism
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 03/2012, Volume 133, Issue 3, pp. 311 - 323
Ranolazine which is currently approved as an antianginal agent reduces the Na-dependent Ca overload via inhibition of the late sodium current (late I ) and...
Heart failure | Ischemia | Atrial fibrillation | Angina | Diabetes | Ca overload | Late Na current | Arrhythmias | Ranolazine | LATE SODIUM CURRENT | INTACT PORCINE HEART | ACUTE CORONARY SYNDROMES | LONG-QT SYNDROME | RANDOMIZED CONTROLLED-TRIAL | PALMITOYL-L-CARNITINE | FATTY-ACID OXIDATION | ISCHEMIC RAT HEARTS | PHARMACOLOGY & PHARMACY | LATE I-NA | LEFT-VENTRICULAR FUNCTION | Cardiovascular Agents - therapeutic use | Animals | Diabetes Mellitus - physiopathology | Heart Diseases - physiopathology | Humans | Diabetes Mellitus - drug therapy | Acetanilides - therapeutic use | Heart Diseases - drug therapy | Piperazines - therapeutic use | Diabetics | Arrhythmia | Hypoglycemic agents | Angina pectoris | Index Medicus
Heart failure | Ischemia | Atrial fibrillation | Angina | Diabetes | Ca overload | Late Na current | Arrhythmias | Ranolazine | LATE SODIUM CURRENT | INTACT PORCINE HEART | ACUTE CORONARY SYNDROMES | LONG-QT SYNDROME | RANDOMIZED CONTROLLED-TRIAL | PALMITOYL-L-CARNITINE | FATTY-ACID OXIDATION | ISCHEMIC RAT HEARTS | PHARMACOLOGY & PHARMACY | LATE I-NA | LEFT-VENTRICULAR FUNCTION | Cardiovascular Agents - therapeutic use | Animals | Diabetes Mellitus - physiopathology | Heart Diseases - physiopathology | Humans | Diabetes Mellitus - drug therapy | Acetanilides - therapeutic use | Heart Diseases - drug therapy | Piperazines - therapeutic use | Diabetics | Arrhythmia | Hypoglycemic agents | Angina pectoris | Index Medicus
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2015, Volume 187, Issue 1, pp. 66 - 74
Abstract Ranolazine was developed as an antianginal agent and was approved by the Food and Drug Administration in 2006 for use in chronic stable angina...
Cardiovascular | Ventricular tachycardia | Late sodium current | Peak sodium current | Atrial fibrillation | Ranolazine | CHRONIC HEART-FAILURE | CURRENT BLOCKER RANOLAZINE | TORSADES-DE-POINTES | CARDIAC & CARDIOVASCULAR SYSTEMS | CHRONIC STABLE ANGINA | INTACT PORCINE HEART | LATE NA+ CURRENT | ACUTE CORONARY SYNDROMES | LONG-QT SYNDROME | RANDOMIZED CONTROLLED-TRIAL | Heart Conduction System - physiopathology | Atrial Fibrillation - drug therapy | Humans | Sodium Channel Blockers - pharmacology | Heart Conduction System - drug effects | Atrial Fibrillation - physiopathology | Ranolazine - pharmacology | Coronary heart disease | Analysis | Cardiac patients | Anti-arrhythmia drugs
Cardiovascular | Ventricular tachycardia | Late sodium current | Peak sodium current | Atrial fibrillation | Ranolazine | CHRONIC HEART-FAILURE | CURRENT BLOCKER RANOLAZINE | TORSADES-DE-POINTES | CARDIAC & CARDIOVASCULAR SYSTEMS | CHRONIC STABLE ANGINA | INTACT PORCINE HEART | LATE NA+ CURRENT | ACUTE CORONARY SYNDROMES | LONG-QT SYNDROME | RANDOMIZED CONTROLLED-TRIAL | Heart Conduction System - physiopathology | Atrial Fibrillation - drug therapy | Humans | Sodium Channel Blockers - pharmacology | Heart Conduction System - drug effects | Atrial Fibrillation - physiopathology | Ranolazine - pharmacology | Coronary heart disease | Analysis | Cardiac patients | Anti-arrhythmia drugs
Journal Article
Heart Rhythm, ISSN 1547-5271, 2014, Volume 11, Issue 10, pp. 1827 - 1835
Background Ischemic heart disease is associated with dual risk for atrial and ventricular arrhythmias. Objective We examined whether selectively targeting late...
Cardiovascular | Depolarization | Heterogeneity | Repolarization | Antiarrhythmic drugs | Late INa | Ventricular ischemia | Atrial fibrillation | Atrial ischemia | Ventricular fibrillation | Late Ina | Antiarrhythmicdrugs | Ventricularischemia | Atrialischemia | FIBRILLATION | CARDIAC & CARDIOVASCULAR SYSTEMS | MECHANISM | Late I-Na | INTACT PORCINE HEART | CARDIAC-ARRHYTHMIA | VULNERABILITY | SUPPRESSION | TRIAL | POTENT | RANOLAZINE | T-WAVE ALTERNANS | Triazoles - administration & dosage | Coronary Stenosis - complications | Injections, Intravenous | Pyridines - administration & dosage | Ventricular Fibrillation - drug therapy | Atrial Fibrillation - drug therapy | Male | Treatment Outcome | Heart Conduction System - drug effects | Atrial Fibrillation - physiopathology | Ventricular Fibrillation - etiology | Dose-Response Relationship, Drug | Animals | Heart Conduction System - physiopathology | Time Factors | Swine | Coronary Stenosis - physiopathology | Sodium Channel Blockers - administration & dosage | Atrial Fibrillation - etiology | Electrocardiography | Ventricular Fibrillation - physiopathology | Heart | Ischemia | Heart diseases | Electrocardiogram
Cardiovascular | Depolarization | Heterogeneity | Repolarization | Antiarrhythmic drugs | Late INa | Ventricular ischemia | Atrial fibrillation | Atrial ischemia | Ventricular fibrillation | Late Ina | Antiarrhythmicdrugs | Ventricularischemia | Atrialischemia | FIBRILLATION | CARDIAC & CARDIOVASCULAR SYSTEMS | MECHANISM | Late I-Na | INTACT PORCINE HEART | CARDIAC-ARRHYTHMIA | VULNERABILITY | SUPPRESSION | TRIAL | POTENT | RANOLAZINE | T-WAVE ALTERNANS | Triazoles - administration & dosage | Coronary Stenosis - complications | Injections, Intravenous | Pyridines - administration & dosage | Ventricular Fibrillation - drug therapy | Atrial Fibrillation - drug therapy | Male | Treatment Outcome | Heart Conduction System - drug effects | Atrial Fibrillation - physiopathology | Ventricular Fibrillation - etiology | Dose-Response Relationship, Drug | Animals | Heart Conduction System - physiopathology | Time Factors | Swine | Coronary Stenosis - physiopathology | Sodium Channel Blockers - administration & dosage | Atrial Fibrillation - etiology | Electrocardiography | Ventricular Fibrillation - physiopathology | Heart | Ischemia | Heart diseases | Electrocardiogram
Journal Article
Heart Rhythm, ISSN 1547-5271, 2015, Volume 12, Issue 2, pp. 409 - 418
Background Application of antiarrhythmic compounds is limited by both proarrhythmic and extracardiac toxicities, as well as incomplete antiarrhythmic efficacy....
Cardiovascular | Calcium-activated potassium channel | Combination therapy | Flecainide | Lidocaine | Ranolazine | Calcium-activatedpotassiumchannel | INDUCED ARRHYTHMIAS | AMIODARONE | SODIUM | CARDIAC & CARDIOVASCULAR SYSTEMS | INTACT PORCINE HEART | BLOCK | PROLONGATION | COMBINATION | FLecainide | VENTRICULAR REPOLARIZATION | Acetanilides - pharmacology | Voltage-Gated Sodium Channels - drug effects | Guinea Pigs | Atrial Fibrillation - drug therapy | Anti-Arrhythmia Agents - pharmacology | Electrocardiography - drug effects | Flecainide - pharmacology | Atrial Fibrillation - physiopathology | Piperazines - pharmacology | Small-Conductance Calcium-Activated Potassium Channels - metabolism | Small-Conductance Calcium-Activated Potassium Channels - antagonists & inhibitors | Drug Synergism | Atrial Fibrillation - metabolism | Animals | Voltage-Gated Sodium Channel Blockers - pharmacology | Female | Drug Therapy, Combination | Voltage-Gated Sodium Channels - metabolism | Disease Models, Animal | Index Medicus
Cardiovascular | Calcium-activated potassium channel | Combination therapy | Flecainide | Lidocaine | Ranolazine | Calcium-activatedpotassiumchannel | INDUCED ARRHYTHMIAS | AMIODARONE | SODIUM | CARDIAC & CARDIOVASCULAR SYSTEMS | INTACT PORCINE HEART | BLOCK | PROLONGATION | COMBINATION | FLecainide | VENTRICULAR REPOLARIZATION | Acetanilides - pharmacology | Voltage-Gated Sodium Channels - drug effects | Guinea Pigs | Atrial Fibrillation - drug therapy | Anti-Arrhythmia Agents - pharmacology | Electrocardiography - drug effects | Flecainide - pharmacology | Atrial Fibrillation - physiopathology | Piperazines - pharmacology | Small-Conductance Calcium-Activated Potassium Channels - metabolism | Small-Conductance Calcium-Activated Potassium Channels - antagonists & inhibitors | Drug Synergism | Atrial Fibrillation - metabolism | Animals | Voltage-Gated Sodium Channel Blockers - pharmacology | Female | Drug Therapy, Combination | Voltage-Gated Sodium Channels - metabolism | Disease Models, Animal | Index Medicus
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 2013, Volume 61, pp. 44 - 50
Abstract In this article we review the late Na current which functionally can be measured using patch-clamp electrophysiology (INa,late ). This current is...
Cardiovascular | Heart failure | Angina | Ischemia | INa,late | Arrhythmias | Ranolazine | LATE SODIUM CURRENT | CHRONIC HEART-FAILURE | CARDIAC & CARDIOVASCULAR SYSTEMS | I-Na,I-late | INTACT PORCINE HEART | ACUTE CORONARY SYNDROMES | LONG-QT SYNDROME | ATRIAL-FIBRILLATION | CELL BIOLOGY | PALMITOYL-L-CARNITINE | FATTY-ACID OXIDATION | RAT VENTRICULAR MYOCYTES | PROTEIN-KINASE-II | Arrhythmias, Cardiac - metabolism | Myocardial Contraction | Myocardial Ischemia - metabolism | Atrial Fibrillation - drug therapy | Humans | Heart Failure - physiopathology | Sodium Channel Blockers - pharmacology | Heart Failure - metabolism | Atrial Fibrillation - physiopathology | Myocardial Ischemia - drug therapy | Arrhythmias, Cardiac - physiopathology | Heart Failure - drug therapy | Atrial Fibrillation - metabolism | Arrhythmias, Cardiac - drug therapy | Animals | Calcium - physiology | Myocardium - metabolism | Myocardial Ischemia - physiopathology | Sodium Channel Blockers - therapeutic use
Cardiovascular | Heart failure | Angina | Ischemia | INa,late | Arrhythmias | Ranolazine | LATE SODIUM CURRENT | CHRONIC HEART-FAILURE | CARDIAC & CARDIOVASCULAR SYSTEMS | I-Na,I-late | INTACT PORCINE HEART | ACUTE CORONARY SYNDROMES | LONG-QT SYNDROME | ATRIAL-FIBRILLATION | CELL BIOLOGY | PALMITOYL-L-CARNITINE | FATTY-ACID OXIDATION | RAT VENTRICULAR MYOCYTES | PROTEIN-KINASE-II | Arrhythmias, Cardiac - metabolism | Myocardial Contraction | Myocardial Ischemia - metabolism | Atrial Fibrillation - drug therapy | Humans | Heart Failure - physiopathology | Sodium Channel Blockers - pharmacology | Heart Failure - metabolism | Atrial Fibrillation - physiopathology | Myocardial Ischemia - drug therapy | Arrhythmias, Cardiac - physiopathology | Heart Failure - drug therapy | Atrial Fibrillation - metabolism | Arrhythmias, Cardiac - drug therapy | Animals | Calcium - physiology | Myocardium - metabolism | Myocardial Ischemia - physiopathology | Sodium Channel Blockers - therapeutic use
Journal Article
Expert Opinion on Drug Delivery, ISSN 1742-5247, 10/2017, Volume 14, Issue 10, pp. 1227 - 1239
Introduction: Local myocardial delivery (LMD) of therapeutic agents is a promising strategy that aims to treat various myocardial pathologies. It is designed...
intrapericardial drug delivery | Epicardial drug delivery | heart disease | therapy | intramyocardial drug delivery | INTACT PORCINE HEART | CONTROLLED-RELEASE | BONE-MARROW-CELLS | POSTOPERATIVE ATRIAL-FIBRILLATION | ISCHEMIC-HEART-DISEASE | IMPROVES CARDIAC-FUNCTION | PLATELET-RICH PLASMA | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | CORONARY-ARTERY-DISEASE | LEFT-VENTRICULAR FUNCTION | Stem Cell Transplantation | Drug Administration Routes | Gene Transfer Techniques | Animals | Humans | Myocardium - metabolism | Intercellular Signaling Peptides and Proteins - administration & dosage | Pharmaceutical Preparations - administration & dosage | Cardiomyopathies - therapy | Drug Delivery Systems
intrapericardial drug delivery | Epicardial drug delivery | heart disease | therapy | intramyocardial drug delivery | INTACT PORCINE HEART | CONTROLLED-RELEASE | BONE-MARROW-CELLS | POSTOPERATIVE ATRIAL-FIBRILLATION | ISCHEMIC-HEART-DISEASE | IMPROVES CARDIAC-FUNCTION | PLATELET-RICH PLASMA | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | CORONARY-ARTERY-DISEASE | LEFT-VENTRICULAR FUNCTION | Stem Cell Transplantation | Drug Administration Routes | Gene Transfer Techniques | Animals | Humans | Myocardium - metabolism | Intercellular Signaling Peptides and Proteins - administration & dosage | Pharmaceutical Preparations - administration & dosage | Cardiomyopathies - therapy | Drug Delivery Systems
Journal Article
Advances in Clinical and Experimental Medicine, ISSN 1899-5276, 11/2016, Volume 25, Issue 6, pp. 1249 - 1254
Background. Swine are a well-recognized animal model for human cardiovascular diseases. Despite the widespread use of porcine model in experimental...
Heart | Swine | Reference values | Electrophysiology study | swine | FIBRILLATION | MEDICINE, RESEARCH & EXPERIMENTAL | reference values | electrophysiology study | CARDIOMYOPATHY | INTACT PORCINE HEART | ABLATION | MODEL | heart | ECHOCARDIOGRAPHIC-ASSESSMENT | Heart Rate - physiology | Reference Values | Animals | Electrophysiology - methods | Sus scrofa | Heart - physiology
Heart | Swine | Reference values | Electrophysiology study | swine | FIBRILLATION | MEDICINE, RESEARCH & EXPERIMENTAL | reference values | electrophysiology study | CARDIOMYOPATHY | INTACT PORCINE HEART | ABLATION | MODEL | heart | ECHOCARDIOGRAPHIC-ASSESSMENT | Heart Rate - physiology | Reference Values | Animals | Electrophysiology - methods | Sus scrofa | Heart - physiology
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 2014, Volume 21, Issue 11, pp. 1271 - 1278
Ranolazine has primarily been developed and so far approved as an antianginal drug. However, it also has potentially interesting and relevant antiarrhythmic...
Late sodium current | Proarrhythmia | Post-repolarization refractoriness | Atrial fibrillation | Ranolazine | Ventricular fibrillation | ventricular fibrillation | CHRONIC HEART-FAILURE | CURRENT BLOCKER RANOLAZINE | TORSADES-DE-POINTES | POSTREPOLARIZATION REFRACTORINESS | CHEMISTRY, MEDICINAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | REDUCES VENTRICULAR-ARRHYTHMIAS | INTACT PORCINE HEART | RANDOMIZED CONTROLLED-TRIAL | proarrhythmia | late sodium current | PERSISTENT ATRIAL-FIBRILLATION | ACUTE-CORONARY-SYNDROME | EXPERIMENTAL-MODEL | ranolazine | PHARMACOLOGY & PHARMACY | post-repolarization refractoriness | Arrhythmias, Cardiac - drug therapy | Sodium - chemistry | Atrial Fibrillation - drug therapy | Humans | Anti-Arrhythmia Agents - chemistry | Anti-Arrhythmia Agents - therapeutic use | Electrophysiological Phenomena | Sodium - metabolism | Drug Combinations
Late sodium current | Proarrhythmia | Post-repolarization refractoriness | Atrial fibrillation | Ranolazine | Ventricular fibrillation | ventricular fibrillation | CHRONIC HEART-FAILURE | CURRENT BLOCKER RANOLAZINE | TORSADES-DE-POINTES | POSTREPOLARIZATION REFRACTORINESS | CHEMISTRY, MEDICINAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | REDUCES VENTRICULAR-ARRHYTHMIAS | INTACT PORCINE HEART | RANDOMIZED CONTROLLED-TRIAL | proarrhythmia | late sodium current | PERSISTENT ATRIAL-FIBRILLATION | ACUTE-CORONARY-SYNDROME | EXPERIMENTAL-MODEL | ranolazine | PHARMACOLOGY & PHARMACY | post-repolarization refractoriness | Arrhythmias, Cardiac - drug therapy | Sodium - chemistry | Atrial Fibrillation - drug therapy | Humans | Anti-Arrhythmia Agents - chemistry | Anti-Arrhythmia Agents - therapeutic use | Electrophysiological Phenomena | Sodium - metabolism | Drug Combinations
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 12/2010, Volume 19, Issue 12, pp. 1465 - 1474
Atrial fibrillation is the most common arrhythmia seen in clinical practice, and novel pharmacological approaches for treatment are sought. Ranolazine (Ranexa;...
antiarrhythmic | ranolazine | atrial fibrillation | TORSADES-DE-POINTES | ANTIARRHYTHMIC COMPOUND AZD7009 | SODIUM-CHANNEL BLOCK | NA+ CURRENTS | CHRONIC STABLE ANGINA | INTACT PORCINE HEART | ANTIANGINAL AGENT | RANDOMIZED CONTROLLED-TRIAL | VENTRICULAR MYOCYTES | INTRAVENOUS AZD7009 | PHARMACOLOGY & PHARMACY | Drug Evaluation, Preclinical - methods | Evidence-Based Medicine - methods | Acetanilides - pharmacology | Atrial Fibrillation - drug therapy | Humans | Treatment Outcome | Piperazines - chemistry | Piperazines - therapeutic use | Atrial Fibrillation - physiopathology | Piperazines - pharmacology | Ranolazine | Evidence-Based Medicine - trends | Ion Channel Gating - physiology | Animals | Acetanilides - chemistry | Acetanilides - therapeutic use | Clinical Trials as Topic - methods | Ion Channel Gating - drug effects
antiarrhythmic | ranolazine | atrial fibrillation | TORSADES-DE-POINTES | ANTIARRHYTHMIC COMPOUND AZD7009 | SODIUM-CHANNEL BLOCK | NA+ CURRENTS | CHRONIC STABLE ANGINA | INTACT PORCINE HEART | ANTIANGINAL AGENT | RANDOMIZED CONTROLLED-TRIAL | VENTRICULAR MYOCYTES | INTRAVENOUS AZD7009 | PHARMACOLOGY & PHARMACY | Drug Evaluation, Preclinical - methods | Evidence-Based Medicine - methods | Acetanilides - pharmacology | Atrial Fibrillation - drug therapy | Humans | Treatment Outcome | Piperazines - chemistry | Piperazines - therapeutic use | Atrial Fibrillation - physiopathology | Piperazines - pharmacology | Ranolazine | Evidence-Based Medicine - trends | Ion Channel Gating - physiology | Animals | Acetanilides - chemistry | Acetanilides - therapeutic use | Clinical Trials as Topic - methods | Ion Channel Gating - drug effects
Journal Article
Sports Medicine, ISSN 0112-1642, 1996, Volume 22, Issue 4, pp. 228 - 250
This review discusses the role of the endothelium in the regulation of coronary vascular function. The role of endothelium-mediated mechanisms at rest, during...
INTACT PORCINE HEARTS | CONSCIOUS DOGS | SPORT SCIENCES | ATRIAL-NATRIURETIC-PEPTIDE | CAPILLARY HYDRAULIC CONDUCTIVITY | NITRIC-OXIDE SYNTHESIS | RELAXING FACTOR | MYOCARDIAL OXYGEN-CONSUMPTION | PERFUSED RABBIT HEART | GUINEA-PIG HEART | BLOOD-FLOW
INTACT PORCINE HEARTS | CONSCIOUS DOGS | SPORT SCIENCES | ATRIAL-NATRIURETIC-PEPTIDE | CAPILLARY HYDRAULIC CONDUCTIVITY | NITRIC-OXIDE SYNTHESIS | RELAXING FACTOR | MYOCARDIAL OXYGEN-CONSUMPTION | PERFUSED RABBIT HEART | GUINEA-PIG HEART | BLOOD-FLOW
Journal Article
Journal of Thoracic and Cardiovascular Surgery, ISSN 0022-5223, 1992, Volume 104, Issue 3, pp. 569 - 578
A left ventricular assist device was used to produce a 90 % reduction in peak systolic left ventricular pressure in pigs with congestive heart failure, and the...
SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | OPERATING-ROOM MODEL | INTACT HEART | PERFORMANCE | CONSEQUENCES | TACHYCARDIA | CANINE HEART | DIMENSION RELATIONSHIP | PRESSURE-VOLUME RELATIONSHIP | DOG | TRANSPLANTATION | Blood Pressure | Heart - physiopathology | Stroke Volume | Heart Failure - therapy | Animals | Models, Cardiovascular | Swine | Cardiac Output | Heart Failure - physiopathology | Hemodynamics | Heart-Assist Devices | Pulmonary Artery - physiology
SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | OPERATING-ROOM MODEL | INTACT HEART | PERFORMANCE | CONSEQUENCES | TACHYCARDIA | CANINE HEART | DIMENSION RELATIONSHIP | PRESSURE-VOLUME RELATIONSHIP | DOG | TRANSPLANTATION | Blood Pressure | Heart - physiopathology | Stroke Volume | Heart Failure - therapy | Animals | Models, Cardiovascular | Swine | Cardiac Output | Heart Failure - physiopathology | Hemodynamics | Heart-Assist Devices | Pulmonary Artery - physiology
Journal Article
Artificial Organs, ISSN 0160-564X, 05/2018, Volume 42, Issue 5, pp. 540 - 548
Bovine and porcine pericardia are currently used for manufacturing prosthetic heart valves: their design has become an increasingly important area of...
Percutaneous valves | Porcine pericardium | Preconditioning | Bovine pericardium | Heart valves | MECHANICS | ENGINEERING, BIOMEDICAL | INTACT | TIME | TEAR RESISTANCE | TRANSPLANTATION | Tensile Strength | Heart Valve Prosthesis | Bioprosthesis | Materials Testing | Collagen - metabolism | Biomechanical Phenomena | Animals | Pericardium - physiology | Cattle | Swine | Pericardium - ultrastructure | Weight-Bearing | Collagen - analysis | Pericardium - chemistry | Collagen | Biological products | Prostheses | Deformation | Deformation mechanisms | Collagens | Mechanical properties | Valves | Pericardium | Fibers | Recruitment | Mechanical analysis | Biomaterials | Biomedical materials
Percutaneous valves | Porcine pericardium | Preconditioning | Bovine pericardium | Heart valves | MECHANICS | ENGINEERING, BIOMEDICAL | INTACT | TIME | TEAR RESISTANCE | TRANSPLANTATION | Tensile Strength | Heart Valve Prosthesis | Bioprosthesis | Materials Testing | Collagen - metabolism | Biomechanical Phenomena | Animals | Pericardium - physiology | Cattle | Swine | Pericardium - ultrastructure | Weight-Bearing | Collagen - analysis | Pericardium - chemistry | Collagen | Biological products | Prostheses | Deformation | Deformation mechanisms | Collagens | Mechanical properties | Valves | Pericardium | Fibers | Recruitment | Mechanical analysis | Biomaterials | Biomedical materials
Journal Article
14.
Full Text
Left ventricular unloading decreases rate of isovolumic right ventricular pressure decline
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0002-9513, 1993, Volume 265, Issue 5, pp. H1663 - H1669
To determine whether direct ventricular interaction affects right ventricular (RV) relaxation, we compared the minimum rate of change of RV pressure...
ventricular interaction | porcine intact heart | right ventricular function | ventricular relaxation | INTACT CANINE HEART | PHYSIOLOGY | VENTRICULAR INTERACTION | ISCHEMIA | CARDIAC-MUSCLE | TIME-COURSE | HYPOXIA | INTERDEPENDENCE | VENTRICULAR RELAXATION | RIGHT VENTRICULAR FUNCTION | PORCINE INTACT HEART | LOAD-DEPENDENT RELAXATION | FALL | HEMODYNAMIC DETERMINANTS | Myocardial Contraction | Heart - anatomy & histology | Heart Rate | Ventricular Function, Left | Heart - physiology | Male | Systole | Pulmonary Artery - physiology | Animals | Pericardium - physiology | Swine | Electrocardiography | Female | Muscle, Smooth, Vascular - physiology
ventricular interaction | porcine intact heart | right ventricular function | ventricular relaxation | INTACT CANINE HEART | PHYSIOLOGY | VENTRICULAR INTERACTION | ISCHEMIA | CARDIAC-MUSCLE | TIME-COURSE | HYPOXIA | INTERDEPENDENCE | VENTRICULAR RELAXATION | RIGHT VENTRICULAR FUNCTION | PORCINE INTACT HEART | LOAD-DEPENDENT RELAXATION | FALL | HEMODYNAMIC DETERMINANTS | Myocardial Contraction | Heart - anatomy & histology | Heart Rate | Ventricular Function, Left | Heart - physiology | Male | Systole | Pulmonary Artery - physiology | Animals | Pericardium - physiology | Swine | Electrocardiography | Female | Muscle, Smooth, Vascular - physiology
Journal Article
Molecular and Cellular Biochemistry, ISSN 0300-8177, 11/1997, Volume 176, Issue 1, pp. 211 - 218
Previously we showed in an in situ porcine model that the thiadiazinone derivative [+]EMD 60263, a Ca2+ sensitizer without phosphodiesterase III inhibitory...
Life Sciences | Biochemistry, general | cardiac myofibrils | human, pig | thiadiazinone derivatives | Medical Biochemistry | Oncology | Ca 2+ stimulated Mg 2+ -ATPase | Cardiology | stunning | cardiac sarcoplasmic reticulum | ATPASE ACTIVITY | CARDIAC MYOCYTES | INTACT | SARCOPLASMIC-RETICULUM | CALCIUM SENSITIVITY | pig | PHOSPHATIDYLINOSITOL CYCLE | TROPONIN-I | CELL BIOLOGY | CANINE MYOCARDIUM | Ca2+ stimulated Mg2+-ATPase | MGATPASE ACTIVITY | CA-2 | human | Proteins | Kinases | Phosphorylation
Life Sciences | Biochemistry, general | cardiac myofibrils | human, pig | thiadiazinone derivatives | Medical Biochemistry | Oncology | Ca 2+ stimulated Mg 2+ -ATPase | Cardiology | stunning | cardiac sarcoplasmic reticulum | ATPASE ACTIVITY | CARDIAC MYOCYTES | INTACT | SARCOPLASMIC-RETICULUM | CALCIUM SENSITIVITY | pig | PHOSPHATIDYLINOSITOL CYCLE | TROPONIN-I | CELL BIOLOGY | CANINE MYOCARDIUM | Ca2+ stimulated Mg2+-ATPase | MGATPASE ACTIVITY | CA-2 | human | Proteins | Kinases | Phosphorylation
Journal Article
British journal of pharmacology, ISSN 0007-1188, 2018, Volume 175, Issue 12, pp. 2470 - 2482
Background and Purpose: Enhanced late sodium current (late INa) in heart failure and long QT syndrome type 3 is proarrhythmic. This study investigated the...
ATRIOVENTRICULAR-BLOCK DOG | INTACT PORCINE MODEL | CHRONIC AV-BLOCK | SHORT-TERM VARIABILITY | EARLY AFTERDEPOLARIZATIONS | VENTRICULAR-TACHYCARDIA | LATE NA+ CURRENT | HEART MODEL | PHARMACOLOGY & PHARMACY | LONG-QT-SYNDROME | LATE I-NA | Triazoles - administration & dosage | Arrhythmias, Cardiac - chemically induced | Pyridines - administration & dosage | Anti-Arrhythmia Agents - pharmacology | Torsades de Pointes - chemically induced | Anti-Arrhythmia Agents - administration & dosage | Phenethylamines | Dose-Response Relationship, Drug | Triazoles - pharmacology | Arrhythmias, Cardiac - drug therapy | Animals | Myocytes, Cardiac - drug effects | Sulfonamides | Dogs | Pyridines - pharmacology | Torsades de Pointes - drug therapy | Heart | Arrhythmia | Cardiomyocytes | Mapping | Dispersion | Mode of action | Inhibitors | Sodium | Torsades de pointes | Electrocardiography | Long QT syndrome | In vivo methods and tests | Ventricle | Heart diseases | Research Papers | Research Paper
ATRIOVENTRICULAR-BLOCK DOG | INTACT PORCINE MODEL | CHRONIC AV-BLOCK | SHORT-TERM VARIABILITY | EARLY AFTERDEPOLARIZATIONS | VENTRICULAR-TACHYCARDIA | LATE NA+ CURRENT | HEART MODEL | PHARMACOLOGY & PHARMACY | LONG-QT-SYNDROME | LATE I-NA | Triazoles - administration & dosage | Arrhythmias, Cardiac - chemically induced | Pyridines - administration & dosage | Anti-Arrhythmia Agents - pharmacology | Torsades de Pointes - chemically induced | Anti-Arrhythmia Agents - administration & dosage | Phenethylamines | Dose-Response Relationship, Drug | Triazoles - pharmacology | Arrhythmias, Cardiac - drug therapy | Animals | Myocytes, Cardiac - drug effects | Sulfonamides | Dogs | Pyridines - pharmacology | Torsades de Pointes - drug therapy | Heart | Arrhythmia | Cardiomyocytes | Mapping | Dispersion | Mode of action | Inhibitors | Sodium | Torsades de pointes | Electrocardiography | Long QT syndrome | In vivo methods and tests | Ventricle | Heart diseases | Research Papers | Research Paper
Journal Article
Resuscitation, ISSN 0300-9572, 2014, Volume 85, Issue 11, pp. 1586 - 1593
Abstract Background High quality chest